• Bayer’s Science@Scale Platform and the Role For NVIDIA Federated Learning

    Bio-IT World | NVIDIA has announced the next generation of federated learning: Clara 4.0 with global orchestration of edge clients, and an addition to privacy-preserving homomorphic encryption. David Ruau, VP, head of Global Data Assets and Decision Science at Bayer, outlined Bayer’s work with NVIDIA to incorporate Clara Federated Learning.

    Apr 15, 2021

  • Mutational Signatures In Cancer Improved By Supervised Machine Learning

    Bio-IT World | Researchers at the Johns Hopkins Kimmel Cancer Center have a newly developed supervised machine learning algorithm that does the best job yet of connecting tissue-specific cancers to potential disease-driving factors.

    Apr 14, 2021

  • Pharma, Life Sciences Partnerships Driven By NVIDIA AI and Processors

    Bio-IT World | At NVIDIA’s GTC event starting this week, NVIDIA CEO Jensen Huang outlined—among other things—partnerships expanding Clara Discovery, NVIDIA’s computational platform for healthcare.

    Apr 12, 2021

  • Collaboration Is Key to Combatting Cybercrime

    Bio-IT World | Cybersecurity challenges have only escalated during the COVID-19 crisis, particularly in the fields of science and healthcare. The past year has seen a dramatic increase in the number of breaches and ransomware attacks for the enterprise networks of labs and healthcare facilities.

    Apr 9, 2021

  • Drugs Repurposed To Tap Immune System In Fight Against Pathogens

    Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease.

    Apr 6, 2021

  • Follow the Money: Single-Cell Multiomics, Data Networks, Security

    Bio-IT World | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.

    Apr 1, 2021

  • Viruses (And People) Play A ‘Signaling Game’ With Strangers And Dangers

    Bio-IT World | Mathematically speaking, the cytokine storm seen with severe COVID-19 and the out-of-control behavior of QAnon conspiracy theorists are not really all that different, according to Bud Mishra, a professor at New York University's Courant Institute of Mathematical Sciences. Both invoke a stranger-danger “signaling game” that would also explain how messenger RNA (mRNA) and transfer RNA (tRNA) came to be cellular co-occupants some three and half billion years ago.

    Mar 31, 2021

  • Global Research Spanning 30+ Countries to Examine COVID’s Impact on the Brain

    Bio-IT World | While it isn’t clear just yet how the coronavirus could impact cognition over the long haul, a global group of researchers is looking to learn more.

    Mar 30, 2021

  • 5 Important AI Discoveries Generated by COVID-19

    Bio-IT World | Life sciences leaders are outlining the learnings from COVID-19 to move forward, hopefully stronger, wiser, and better than before.

    Mar 26, 2021

  • New Framework For Developing Polygenic Risk Scores

    Bio-IT World | Last week a research team published a 22-item framework in Nature that identifies the minimal polygenic risk score-related information that scientists should include in their studies.

    Mar 25, 2021

  • Eric Dishman on Paul Allen, Andy Grove, and All of Us

    Bio-IT World | TRENDS FROM THE TRENCHES—It’s been a little over a year since Eric Dishman stepped down as CEO of the National Institutes of Health’s All of Us program and took on the role of Chief Innovation Officer. Now he talks about his early training under Paul Allen of Microsoft and Andy Grove of Intel still plays into his decisions.

    Mar 23, 2021

  • Jay Flatley Steps Down From Illumina Board

    Bio-IT World | Illumina has announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021.

    Mar 18, 2021

  • It’s Time to Bet on the Underdog

    Bio-IT World | The unprecedented accomplishment that is Moderna’s innovative mRNA Covid-19 vaccine proves—among other things—that a shift has come to life sciences. It’s time to bet on the underdog.

    Mar 18, 2021

  • Stanford Researchers Find Culprit In Muscle Aging And How To Knock It Down

    Bio-IT World | For well over a decade now, scientists have been experimenting with “couch potato” drugs that could confer the benefits of exercise without having to flex a muscle. The latest candidate is a small molecule inhibitor impeding the degradation of prostaglandin E2 (PGE2), recently shown to act directly on mature muscle fibers to prevent deleterious molecular changes that arise with aging.

    Mar 17, 2021

  • Desktop PCs Supercharged to Rival Pricey Supercomputers

    Bio-IT World | Researchers at the University of Sussex have figured out a way to give desktop PCs the same horsepower as supercomputers, which could help democratize research involving large-scale brain simulations.

    Mar 15, 2021

  • mRNA Inconsistencies, Antibody Cocktails, Antibody Mapping: COVID-19 Updates

    Bio-IT World | Top COVID-19 news and research stories of the week: new variants will evade antibodies, inconsistencies in the Pfizer-BioNTech vaccine batches, and a new COVID Antibody Epitope Mapping service.

    Mar 12, 2021

  • See Your Data: Collaborative Dictionary Authoring

    Bio-IT World | The foundation of a data commons is the data dictionary—the map or model populated with all of the data within an organization and the relationships between them. The hardest part of FAIR is the “I”—interoperability, says Bill Van Etten, senior scientific consultant at BioTeam. The data dictionary is what brings you from FAR to FAIR.

    Mar 9, 2021

  • Omics, Methylation, AI-Driven Discovery, Online Education: News and Products for February

    Bio-IT World | New products and company updates from around Bio-IT including Seven Bridges’ partnership with Pfizer, Illumina’s Russian approval, new methylation detection platform from Twist, and more.

    Mar 8, 2021

  • Nanotechnology-Based Vaccine Candidate, Blood Type A Raises Risk, Neanderthal-Derived Protein Offers Protection: COVID-19 Updates

    Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.

    Mar 5, 2021

  • Spatial Surge: AGBT Updates On Single-Cell and Spatial Genomics, In Situ Analysis, More

    Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.

    Mar 4, 2021